A platform for research: civil engineering, architecture and urbanism
A platform for research: civil engineering, architecture and urbanism
Biopharmaceutical drug development modeling and portfolio management.
Current pressures of cost and speed to market are driving the need for more effective means of assessing the value and risks of drug portfolios. This thesis presents research to generate a prototype computer-aided tool to predict the process and business outcomes for portfolios of biopharmaceutical drugs proceeding through the development pathway. The tool was built using a discrete-event simulation package, thus facilitating the dynamic nature of drug development decisions to be captured. The framework uses a hierarchical approach to incorporate the interactions between drug development activities, the available resources and databases of information. In addition to the business and process issues, the risks involved in the process of drug development have also been incorporated into the tool. The application of the tool for assessing drug portfolios under uncertainty is demonstrated via case studies. In the first, the tool was used to perform sensitivity and scenario analysis on the portfolio net present value (NPV). Contour plots were generated that provide the ability to plan for a range of contingencies including uncertainties in manufacturing efficiencies, product demand and the market share captured. The second case study was used to assess the impact of different manufacturing strategies on the portfolio NPV under uncertainty. This example was based on a biopharmaceutical company considering whether to risk building a facility for the commercial manufacture of its antibodies and if so, when to start building, or whether to rely on a contract manufacturer throughout the development cycle and market manufacture. The effects of uncertainties were analysed using Monte Carlo simulation methods. The study highlighted the benefits of incorporating uncertainties when ranking different strategies. The third case study looked at the selection of drug candidates for a drug portfolio. The risk and reward of different portfolios were computed using Monte Carlo simulations. The 'Efficient Frontier' method was used to ...
Biopharmaceutical drug development modeling and portfolio management.
Current pressures of cost and speed to market are driving the need for more effective means of assessing the value and risks of drug portfolios. This thesis presents research to generate a prototype computer-aided tool to predict the process and business outcomes for portfolios of biopharmaceutical drugs proceeding through the development pathway. The tool was built using a discrete-event simulation package, thus facilitating the dynamic nature of drug development decisions to be captured. The framework uses a hierarchical approach to incorporate the interactions between drug development activities, the available resources and databases of information. In addition to the business and process issues, the risks involved in the process of drug development have also been incorporated into the tool. The application of the tool for assessing drug portfolios under uncertainty is demonstrated via case studies. In the first, the tool was used to perform sensitivity and scenario analysis on the portfolio net present value (NPV). Contour plots were generated that provide the ability to plan for a range of contingencies including uncertainties in manufacturing efficiencies, product demand and the market share captured. The second case study was used to assess the impact of different manufacturing strategies on the portfolio NPV under uncertainty. This example was based on a biopharmaceutical company considering whether to risk building a facility for the commercial manufacture of its antibodies and if so, when to start building, or whether to rely on a contract manufacturer throughout the development cycle and market manufacture. The effects of uncertainties were analysed using Monte Carlo simulation methods. The study highlighted the benefits of incorporating uncertainties when ranking different strategies. The third case study looked at the selection of drug candidates for a drug portfolio. The risk and reward of different portfolios were computed using Monte Carlo simulations. The 'Efficient Frontier' method was used to ...
Biopharmaceutical drug development modeling and portfolio management.
Rajapakse, T.A. (author)
2005-01-01
Doctoral thesis, University of London.
Theses
Electronic Resource
English
General biopharmaceutical design criteria
Online Contents | 1994
Injecting Life Into Biopharmaceutical Design
Online Contents | 1994
Retrofitting & building facilities for biopharmaceutical production
| British Library Conference Proceedings | 2001
New developments in biopharmaceutical protein formulation
| British Library Conference Proceedings | 1997